Concert Genetics

In December 2017, Deerfield invested in Concert Genetics, a healthcare information technology firm focused on developing software and analytic tools for genetic testing. Concert Genetics is developing a digital infrastructure to enhance the transparency and efficiency of genetic testing for clinicians, hospitals, laboratories and health insurers.